Partner Investment Management’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Partner Investment Management’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-103,596	Closed	-$491K	–	107
2019 Q2	$491K	Sell	103,596 -255,529	-71%	-$1.43M	0.52%	53
2019 Q1	$2.32M	Sell	359,125 -473,233	-57%	-$2.48M	2.68%	6
2018 Q4	$4.19M	Buy	832,358 +3	+0%	+$21	5.23%	3
2018 Q3	$5.84M	Buy	832,355 +829,833	+32,904%	+$9.2M	4.47%	1
2018 Q2	$32K	Buy	+2,522	New	+$34.5K	0.03%	108

Other funds holding NTGN

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HMC

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Partner Investment Management's NTGN Position: Q3 2019 in Review

Partner Investment Management sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q3 2019, closing a stake of 103,596 shares — an estimated $491K sold.

Partner Investment Management first reported a position in NTGN in Q2 2018 and held it in 5 quarters. The position peaked at $5.84M in Q3 2018. 58 funds tracked by Wall St. Rank hold NTGN as of Q3 2019.

Partner Investment Management reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Partner Investment Management sold 103,596 Neon Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $491K.
Partner Investment Management first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
Partner Investment Management's Neon Therapeutics, Inc. Common Stock position peaked at $5.84M in Q3 2018.
58 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Partner Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.